Mellgen (Shenzhen) Biotechnology Co., Ltd.
Address: 3rd Floor, Building A23, Life Science Industrial Park, Kuichong Sub-district, Dapeng New District, Shenzhen, Guangdong, China

Transdermal Recombinant Protein/Peptides
Award-winning proprietary patented closed cyclic peptide penetration carrier, boasting exceptional proteolytic resistance and cell membrane fluidity modulation to safely transport macromolecular actives up to tens of kilodaltons across the skin barrier.
INCI Name: Aqua, Cyclopeptide-1, Pentylene Glycol, 1,2-Hexanediol
Appearance & Solubility: Clear colorless liquid, odorless, Completely miscible with water
Recommended Dosage: 0.5% - 2.0% (Recommended 1.0%)
Hotline: 136-9197-8530
Award-winning proprietary patented closed cyclic peptide penetration carrier, boasting exceptional proteolytic resistance and cell membrane fluidity modulation to safely transport macromolecular actives up to tens of kilodaltons across the skin barrier.
Scientific Illustration Transdermal Cyclic Peptide cTDP - Mechanism & Scientific Evidence
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.


